George D. Yancopoulos is the Scientific Founder, President, and Chief Scientific Officer at Regeneron. Yancopoulos is the principal inventor of Regeneron’s nine FDA-approved drugs and foundational technologies, including the TRAP technology, VelociGene and VelocImmune. He has been named an Ernst & Young Entrepreneur of the Year and has been pivotal in creating the science-driven, collaborative and highly productive R&D culture at Regeneron.

Yancopoulos attended the Bronx High School of Science and received his MD and PhD from Columbia University.